We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News   Aug 10, 2018 | Original story by Rockland Inc

 
Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article
 
 
 

RELATED ARTICLES

Mouse Model Shows Gene Therapy Vectors Carrying Telomerase Gene Do Not Increase Cancer Risk

News

Gene therapy with telomerase was developed in 2012 and has proved effective in mice against infarction, as well as in mouse models of aplastic anaemia and idiopathic pulmonary fibrosis associated to short telomeres.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

Chips, Light and Coding Moves the Front Line in Beating Bacteria

News

The never-ending fight against bacteria has taken a turn in humanity’s favor with the announcement of a tool that could give the upper hand in drug research.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE